Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Change in Account Payables (2016 - 2020)

Glucotrack's Change in Account Payables history spans 7 years, with the latest figure at -$354000.0 for Q4 2020.

  • For the quarter ending Q4 2020, Change in Account Payables fell 1211.79% year-over-year to -$354000.0, compared with a TTM value of -$714000.0 through Dec 2020, down 19.0%, and an annual FY2025 reading of $325000.0, up 23.57% over the prior year.
  • Change in Account Payables for Q4 2020 was -$354000.0 at Glucotrack, down from $6000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $385660.0 in Q4 2017, with the low at -$908382.0 in Q2 2016.
  • Average Change in Account Payables over 5 years is -$93205.9, with a median of -$96335.0 recorded in 2018.
  • Year-over-year, Change in Account Payables tumbled 3521.4% in 2016 and then surged 217.76% in 2017.
  • Tracing GCTK's Change in Account Payables over 5 years: stood at -$176887.0 in 2016, then skyrocketed by 318.03% to $385660.0 in 2017, then crashed by 124.98% to -$96335.0 in 2018, then soared by 71.99% to -$26986.0 in 2019, then tumbled by 1211.79% to -$354000.0 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Change in Account Payables are -$354000.0 (Q4 2020), $6000.0 (Q3 2020), and -$248000.0 (Q2 2020).